SCHEMBL7031472

SCHEMBL7031472

CCCCCCCCCCCC(=O)Nc1ccc2nc(S)[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK2 Q9NRA0 1/20 0.54
SPHK1 Q9NYA1 1/20 0.54
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 4/20 0.52
HPGD P15428 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 1/20 0.47
POLB P06746 1/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
ENPP2 Q13822 1/20 0.45
DGAT2 Q96PD7 1/20 0.45
PSMB11 A5LHX3 1/20 0.45
PSMA7 O14818 1/20 0.45
PSMB1 P20618 1/20 0.45
PSMA1 P25786 1/20 0.45
PSMA2 P25787 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7794733 1.00 SPHK2 (0.54) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL8656543 0.99 NPC1 (0.54) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL7794731 0.91 SPHK2 (0.54) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL7031470 0.91 SPHK2 (0.54) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL8656540 0.89 SMN1; SMN2 (0.54) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL7795897 0.85 MEN1 (0.50) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL7792628 0.80 SPHK2 (0.48) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL6152612 0.78 LMNA (0.55) SMN1; SMN2LMNAALDH1A1POLBCYP1A2
SCHEMBL3957761 0.78 LMNA (0.52) SPHK2SPHK1NPC1RAB9ASMN1; SMN2
SCHEMBL6608685 0.78 KDM4E (0.61) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583665-B1 Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis FUJI PHOTO FILM CO LTD (JP) 2003-03-05 EP disclosed
US-5387600-A Anticholesterol agents; antilipemic agents FUJI PHOTO FILM CO., LTD. (JP) 1995-02-07 US disclosed
US-5387600-A Anticholesterol agents; antilipemic agents FUJI PHOTO FILM CO., LTD. (JP) 1995-02-07 US disclosed
EP-0583665-A2 Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis FUJI PHOTO FILM CO., LTD. (JP) 1994-02-23 EP disclosed
EP-0583665-A2 Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis FUJI PHOTO FILM CO., LTD. (JP) 1994-02-23 EP disclosed
US-4415650-A VACUUM DEPOSITING AN ORGANIC AND AN INORGANIC COMPOUND ON A SUPPORT; THERMOSENSITIVITY; LASERS FUJI PHOTO FILM CO., LTD. (JP) 1983-11-15 US disclosed
US-4286045-A A SUPPORT HAVING A LAYER OF A CHALCOGENIDE OF GERMANIUM DOPED WITH SILVER OR COPPER; STABILITY; LITHOGRAPHIC PRINTING PLATES FUJI PHOTO FILM CO., LTD. (JP) 1981-08-25 US disclosed
US-4198237-A GERMANIUM SULFIDE FUJI PHOTO FILM CO., LTD. (JP) 1980-04-15 US disclosed
US-4197124-A SILVER OR COPPER AND SULFUR, SELENIUM OR TELLURIUM0 FUJI PHOTO FILM CO., LTD. (JP) 1980-04-08 US disclosed
US-4177072-A HYDROPHILIC AND OLEOPHILIC AREAS FUJI PHOTO FILM CO., LTD. (JP) 1979-12-04 US disclosed